Schedule 13G ownership disclosure
PASITHEA THERAPEUTICS CORP
Common Stock, par value $0.0001 per share · CUSIP: 70261F202
Event date: 2025-05-06
- Filing-level shares
- 371,142.00
- Percent of class
- 5.7%
- Orca Capital AG
Shares: 371,142.00 · Class: 5.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001641172-25-009466
- Form type
- SCHEDULE 13G
- Filer
- Orca Capital AG
- CIK
- CIK 2052389
- Filed
- May 09, 2025
- Reporting period
- May 06, 2025
- Description
- Schedule 13G beneficial ownership